These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17235398)

  • 21. Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
    Fraise AP
    J Med Microbiol; 1997 Jun; 46(6):447-9. PubMed ID: 9379471
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antibiotic susceptibility of Staphylococcus aureus strains isolated in two university hospitals in Rabat, Morocco].
    Elhamzaoui S; Benouda A; Allali F; Abouqual R; Elouennass M
    Med Mal Infect; 2009 Dec; 39(12):891-5. PubMed ID: 19269758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Level Resistance of Staphylococcus aureus to β-Lactam Antibiotics Mediated by Penicillin-Binding Protein 4 (PBP4).
    Hamilton SM; Alexander JAN; Choo EJ; Basuino L; da Costa TM; Severin A; Chung M; Aedo S; Strynadka NCJ; Tomasz A; Chatterjee SS; Chambers HF
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRSA--the tip of the iceberg.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():3-10. PubMed ID: 16524422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on emerging infections: news from the Centers for Disease Control and Prevention.
    Moran GJ; Mount J
    Ann Emerg Med; 2003 Jan; 41(1):148-51. PubMed ID: 12514697
    [No Abstract]   [Full Text] [Related]  

  • 26. Vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus, Taiwan.
    Wang JL; Tseng SP; Hsueh PR; Hiramatsu K
    Emerg Infect Dis; 2004 Sep; 10(9):1702-4. PubMed ID: 15503416
    [No Abstract]   [Full Text] [Related]  

  • 27. Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?
    Luna CM; Bruno D; Aruj P
    Crit Care Med; 2010 Sep; 38(9):1910-2. PubMed ID: 20724890
    [No Abstract]   [Full Text] [Related]  

  • 28. Methicillin-resistant Staphylococcal enterocolitis.
    Schiller B; Chiorazzi N; Farber BF
    Am J Med; 1998 Aug; 105(2):164-6. PubMed ID: 9727825
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
    Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
    Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
    Khatib R; Saeed S; Sharma M; Riederer K; Fakih MG; Johnson LB
    Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):181-5. PubMed ID: 16505987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
    Michel M; Gutmann L
    Lancet; 1997 Jun; 349(9069):1901-6. PubMed ID: 9217771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Do we really need new antibiotics?].
    Putensen C
    Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S83-4. PubMed ID: 25429536
    [No Abstract]   [Full Text] [Related]  

  • 33. ILSMRs (intensifier of beta-lactam-susceptibility in methicillin-resistant Staphylococcus aureus) from Tara [Caesalpinia spinosa (Molina) Kuntze].
    Kondo K; Takaishi Y; Shibata H; Higuti T
    Phytomedicine; 2006 Feb; 13(3):209-12. PubMed ID: 16428032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methicillin-resistant Staphylococcus aureus (MRSA) -- therapy and hygienic measures].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):586-8; quiz 589-92. PubMed ID: 15761788
    [No Abstract]   [Full Text] [Related]  

  • 36. [Methicillin resistant Staphylococcus aureus].
    Shimada K
    Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):436-40. PubMed ID: 1607813
    [No Abstract]   [Full Text] [Related]  

  • 37. Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.
    Tabuchi F; Matsumoto Y; Ishii M; Tatsuno K; Okazaki M; Sato T; Moriya K; Sekimizu K
    J Antibiot (Tokyo); 2017 Jun; 70(6):771-774. PubMed ID: 28196977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methicillin resistant Staphylococcus aureus: where are we now?
    Allen DM
    Singapore Med J; 1991 Feb; 32(1):17-9. PubMed ID: 2017696
    [No Abstract]   [Full Text] [Related]  

  • 39. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
    McConeghy KW; Bleasdale SC; Rodvold KA
    Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus?
    Hota B
    Clin Infect Dis; 2006 Mar; 42(6):785-7. PubMed ID: 16477554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.